Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer

Clinical trial NCT07166263 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07166263
Sponsor: Base Therapeutics (Shanghai) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Gastric Cancer (GC)Colorectal Cancer

Start date: 2025-11-01
Primary completion: 2027-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.